RLMD icon

Relmada Therapeutics

45 hedge funds and large institutions have $265M invested in Relmada Therapeutics in 2019 Q4 according to their latest regulatory filings, with 45 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
45
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.13M
Puts
$5K
Net Calls
Net Calls Change

Top Buyers

1 +$50.7M
2 +$29.9M
3 +$29.7M
4
RI
RTW Investments
New York
+$25.9M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$22.2M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
1
$50.7M
2
$29.9M
3
$29.7M
4
$25.9M
5
$22.2M
6
$14.3M
7
$11.7M
8
$11M
9
$10.5M
10
$8.78M
11
$8.61M
12
$5.58M
13
$5.34M
14
$5.05M
15
$4.48M
16
$4M
17
$3.79M
18
$3.13M
19
$1.92M
20
$1.19M
21
$947K
22
$905K
23
$686K
24
$507K
25
$507K